
Longevity Health Holdings, Inc. (NASDAQ: XAGE) related to its merger with 20/20 BioLabs, Inc. Upon completion of the proposed transaction, Longevity shareholders are expected to own approximately 49.9% of the combined company.
Longevity Health Holdings, Inc. (NASDAQ: XAGE) related to its merger with 20/20 BioLabs, Inc. Upon completion of the proposed transaction, Longevity shareholders are expected to own approximately 49.9% of the combined company.